Featuring the development of a novel RNA-based multiplex assay to diagnose breast cancer subtypes Godfrey Grec…
CAP Today Webinar: Respiratory Testing and Reimbursement
Cost, value, and accuracy in molecular diagnostics A recent webinar from CAP Today offers insight into the fin…
Delivering on the Promise of Personalized Medicine
Yoshihiko Fujita is discovering biomarkers to inform cancer treatment Yoshihiko Fujita is on the Faculty of Me…
MLO Article: Respiratory Testing Requires More Flexibility
Target masking with flex testing can help in a dynamic lab environment An article in Medical Laboratory Observ…
Luminex Licensed Technologies Partner Spotlight: Myriad RBM, Inc.
Improving biomarker testing services Luminex Licensed Technologies Partners represent a diverse set of market …
Investment Needed in Antimicrobial Stewardship
Experts call for funding and staffing improvements In a commentary released last month, infectious diseases ex…
Choosing an MDx Platform
Important factors to consider for meeting a community’s infectious disease needs Recently, clinical laboratori…
Protagen is Taking Biomarkers from the Bench to the Bedside
The FLEXMAP 3D® supports high-throughput discovery of autoantibody biomarker candidates Peter Schulz-Knappe is…
It’s Time to Talk About Blood Poisoning
This September, help raise sepsis awareness Did you know that someone in the U.S. dies from sepsis every two m…
Luminex Licensed Technologies Partner Spotlight: CD Diagnostics
Developing Periprosthetic Joint Infection diagnostic assays Luminex Licensed Technologies Partners represent a…